AMD announced results for the first quarter of 2024, which were mostly in line with analyst expectations. The company's revenue was $5.47 billion, up 36% from last year. Earnings per share (EPS) were $0.62, beating expectations of $0.61. On the other hand, the company presents rather mixed guidance. Results in line with expectations and rather weak guidance show that the company is not able to grow like Nvidia at the moment, which may suggest that despite a strong correction, the company's stock declines may not be over yet. AMD loses approximately 3.6% in after-market quotations. Moreover, SMC shows weaker results (mainly in terms of revenues and guidelines), which also worsens the mood in the chip sector.
Key Points:
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile app- AMD reported Q1 2024 revenue of $5.47 billion, up 36% YoY, meeting analyst expectations.
- EPS of $0.62 beat expectations of $0.61.
- Data Center segment revenue grew 80% YoY to $2.3 billion, driven by strong demand for MI300 AI accelerators and Ryzen and EPYC processors.
- Client segment revenue grew 85% YoY to $1.4 billion but declined 6% sequentially.
- Gaming and Embedded segment revenues declined 48% and 46% YoY, respectively.
- Q2 revenue guidance of $5.4-$6.0 billion below analyst expectations.
- AMD continues to invest heavily in R&D, spending $1.53 billion in Q1.
- The company expects data center demand to remain strong as AI adoption grows.
- AMD faces stiff competition from Intel and Nvidia in data centers, PCs, gaming, and embedded systems.
- The stock is down about 3.6% in after-hours trading, following Intel's downward trend.
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
